Sun Pharma rallies 4% as Credit Suisse upgrades to outperform, sees 23% upside
Most Popular (6 hours)

Advent Xmas celebrated

- heshillongtimes.com

Most Popular (24 hours)

Actor Rita Koiral passes away

- business-standard

VBHC defers initial float plan

- business-standard

Most Popular (a week)

CPM, RSS men hacked in Kannur

- kaumudiglobal.com

Comic book route to solve maths

- business-standard

moneycontrol.com
2 months ago

Sun Pharma rallies 4% as Credit Suisse upgrades to outperform, sees 23% upside

Key risks according to Credit Suisse are Halol resolution delay, Dadra Form 483, and Department of Justice (DOJ) penalty.

Read on the original site


Cement stocks drop

- business-standard

Sensex little c PSU banks down

- http://in.reuters.com/

Sensex little c PSU banks down

- business-standard
Hashtags:   

Sun

 | 

Pharma

 | 

rallies

 | 

Credit

 | 

Suisse

 | 

upgrades

 | 

outperform

 | 

sees

 | 

23%

 |